US 7863047
Intracorporeal medicaments for photodynamic treatment of disease
granted A61KA61K31/352A61K41/0038
Quick answer
US patent 7863047 (Intracorporeal medicaments for photodynamic treatment of disease) held by Provectus Pharmatech, Inc. expires Mon Dec 30 2030 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Provectus Pharmatech, Inc.
- Grant date
- Tue Jan 04 2011 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Dec 30 2030 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 2
- CPC classes
- A61K, A61K31/352, A61K41/0038, A61K41/0057, A61K41/0071